214 related articles for article (PubMed ID: 32718905)
1. BAG3 in Tumor Resistance to Therapy.
De Marco M; Turco MC; Marzullo L
Trends Cancer; 2020 Dec; 6(12):985-988. PubMed ID: 32718905
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
3. BAG3 induces α-SMA expression in human fibroblasts and its over-expression correlates with poorer survival in fibrotic cancer patients.
De Marco M; Del Papa N; Reppucci F; Iorio V; Basile A; Falco A; Iaccarino R; Brongo S; De Caro F; Capunzo M; Turco MC; Rosati A; Marzullo L
J Cell Biochem; 2022 Jan; 123(1):91-101. PubMed ID: 34741483
[TBL] [Abstract][Full Text] [Related]
4. Structural Refinement of 2,4-Thiazolidinedione Derivatives as New Anticancer Agents Able to Modulate the BAG3 Protein.
Ruggiero D; Terracciano S; Lauro G; Pecoraro M; Franceschelli S; Bifulco G; Bruno I
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163936
[TBL] [Abstract][Full Text] [Related]
5. Silencing of BAG3 promotes the sensitivity of ovarian cancer cells to cisplatin via inhibition of autophagy.
Qiu S; Sun L; Jin Y; An Q; Weng C; Zheng J
Oncol Rep; 2017 Jul; 38(1):309-316. PubMed ID: 28628188
[TBL] [Abstract][Full Text] [Related]
6. BAG3 Overexpression and Cytoprotective Autophagy Mediate Apoptosis Resistance in Chemoresistant Breast Cancer Cells.
Das CK; Linder B; Bonn F; Rothweiler F; Dikic I; Michaelis M; Cinatl J; Mandal M; Kögel D
Neoplasia; 2018 Mar; 20(3):263-279. PubMed ID: 29462756
[TBL] [Abstract][Full Text] [Related]
7. Targeting tumor-associated macrophages to reverse antitumor drug resistance.
Li S; Sheng J; Zhang D; Qin H
Aging (Albany NY); 2024 May; 16(11):10165-10196. PubMed ID: 38787372
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of Bcl-2-Associated Athanogene-3 Can Enhance the Efficacy of BGJ398 via Suppressing Migration and Inducing Apoptosis in Gastric Cancer.
Li K; Deng X; Feng G; Chen Y
Dig Dis Sci; 2021 Sep; 66(9):3036-3044. PubMed ID: 33089486
[TBL] [Abstract][Full Text] [Related]
9. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
10. Interference with the HSF1/HSP70/BAG3 Pathway Primes Glioma Cells to Matrix Detachment and BH3 Mimetic-Induced Apoptosis.
Antonietti P; Linder B; Hehlgans S; Mildenberger IC; Burger MC; Fulda S; Steinbach JP; Gessler F; Rödel F; Mittelbronn M; Kögel D
Mol Cancer Ther; 2017 Jan; 16(1):156-168. PubMed ID: 27777286
[TBL] [Abstract][Full Text] [Related]
11. BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10.
Wu K; Yang Y; Zhao J; Zhao S
Cancer Lett; 2016 Feb; 371(1):125-33. PubMed ID: 26655271
[TBL] [Abstract][Full Text] [Related]
12. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.
Khalaf K; Hana D; Chou JT; Singh C; Mackiewicz A; Kaczmarek M
Front Immunol; 2021; 12():656364. PubMed ID: 34122412
[TBL] [Abstract][Full Text] [Related]
13. Discovery and synthesis of the first selective BAG domain modulator of BAG3 as an attractive candidate for the development of a new class of chemotherapeutics.
Terracciano S; Lauro G; Russo A; Vaccaro MC; Vassallo A; De Marco M; Ranieri B; Rosati A; Turco MC; Riccio R; Bifulco G; Bruno I
Chem Commun (Camb); 2018 Jul; 54(55):7613-7616. PubMed ID: 29926854
[TBL] [Abstract][Full Text] [Related]
14. BAG3 promoted starvation-induced apoptosis of thyroid cancer cells via attenuation of autophagy.
Li S; Zhang HY; Wang T; Meng X; Zong ZH; Kong DH; Wang HQ; Du ZX
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2298-307. PubMed ID: 25062457
[TBL] [Abstract][Full Text] [Related]
15. Wnt Inhibition Sensitizes PD-L1 Blockade Therapy by Overcoming Bone Marrow-Derived Myofibroblasts-Mediated Immune Resistance in Tumors.
Huang T; Li F; Cheng X; Wang J; Zhang W; Zhang B; Tang Y; Li Q; Zhou C; Tu S
Front Immunol; 2021; 12():619209. PubMed ID: 33790893
[TBL] [Abstract][Full Text] [Related]
16. Tumour-associated macrophages as a novel target of VEGI-251 in cancer therapy.
Dong X; Huang X; Yao Z; Wu Y; Chen D; Tan C; Lin J; Zhang D; Hu Y; Wu J; Wei G; Zhu X
J Cell Mol Med; 2020 Jul; 24(14):7884-7895. PubMed ID: 32452100
[TBL] [Abstract][Full Text] [Related]
17. Tumour Cell Secretome in Chemoresistance and Tumour Recurrence.
Madden EC; Gorman AM; Logue SE; Samali A
Trends Cancer; 2020 Jun; 6(6):489-505. PubMed ID: 32460003
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.
Kanzaki R; Pietras K
Cancer Sci; 2020 Aug; 111(8):2708-2717. PubMed ID: 32573845
[TBL] [Abstract][Full Text] [Related]
19. An emerging role for BAG3 in gynaecological malignancies.
De Marco M; Falco A; Iaccarino R; Raffone A; Mollo A; Guida M; Rosati A; Chetta M; Genovese G; De Caro F; Capunzo M; Turco MC; Uversky VN; Marzullo L
Br J Cancer; 2021 Sep; 125(6):789-797. PubMed ID: 34099896
[TBL] [Abstract][Full Text] [Related]
20. BAG3 induction is required to mitigate proteotoxicity via selective autophagy following inhibition of constitutive protein degradation pathways.
Rapino F; Jung M; Fulda S
Oncogene; 2014 Mar; 33(13):1713-24. PubMed ID: 23644654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]